For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
This report discusses the Indian pharmaceutical industry in depth, with specific focus on the ten leading domestic India pharmaceutical companies; their key financials since FY2011; their key global markets; their Merger, Acquisition and Joint Venture activity; their Research & Development spending; as well as Strength, Weakness, Opportunity and Threats that each individual company faces. This report also offers a snapshot of the key financials in the India pharmaceutical sector; import / export values, and where the India based pharmaceutical companies are generating their revenue globally. The report concludes with interviews with directors of Ipca Laboratories, Cadila Healthcare and Cipla.
The Indian Pharmaceutical Market - Leading Domestic Companies 2015 also highlights what drives, or restrains, the market for these leading companies;
Key Drivers
- US Generics Market
- JV, Acquisitions & Mergers
- Patent Cliff
- Increased Domestic Health Spending
- Geographic Expansion into Semi-Regulated and Emerging Pharma Markets
- Economies in Drug Production/Manufacture
- Governmental Support
Key Restraints
- Industry Inefficiencies
- Regulatory Non-Compliance
- Price Ceilings
- Intellectual Property Rights / Compulsory Licence
- Inadequate Health Insurance, India
The US generics market has been a massive growth driver for the India pharmaceutical market, with many leading companies in GMR Data's list generating over 50% of their annual revenues from the US generics market. However with access to the US market comes increased scrutiny from the US FDA; nearly all the companies in the top ten have faced warnings from the FDA; ranging from minor procedural infractions to complete manufacturing shutdown.
The report contains over 130 tables & figures across 152 pages and concludes with 3 exclusive interviews with managing directors of 3 leading Indian pharmaceutical companies;
- Cipla
- Cadila Healthcare
- IPCA Laboratories
Companies Mentioned
- Abbott
- AbbVie
- Actelion
- Agila Specialities
- Amgen
- Amgen
- ANVISA Brazil
- Apotex Inc
- Aptil Pharma Limited
- Arab Company for Drug Industries and Medical Appliances
- AstraZeneca
- AstraZeneca Pharma India Limited (AZPIL)
- BASF
- Bayer Healthcare
- Bayer Zydus Pharma
- Betapharm
- Biocon
- Biopharm SPA
- Bristol- Myers Squibb (BMS)
- Cadila Healthcare
- Capital Advisory Group
- Caraco
- Celeris
- Celon Laboratories
- Center of Excellence for Inhalation Research
- Chattem
- Cipla Ltd
- Cipla Medpro
- Claris Lifesciences
- CP Pharmaceuticals
- Curatio Healthcare
- Daiichi Sankyo
- Dishman Pharmaceuticals & Chemicals
- Dr Reddy's Laboratories Ltd.
- Dumex
- Duomed Produtos Farmaceuticos
- DUSA
- Elder Pharmaceuticals Ltd
- Endo Pharmaceuticals
- Espharma GmbH
- Farma World Importacao e Exportacao de Medicamentos LTDA
- Fleming Labs
- Fujifilm Diosynth Bio technologies
- GAVIS Pharmaceuticals LLC
- Generica KG Germany
- Gilead Sciences Inc.
- GlaxoSmithKline (GSK)
- Glenmark Generics Ltd.
- Glenmark Pharmaceuticals Ltd.
- Health Canada
- Heumann Pharma GmbH & Co.
- Heunet Pharma GmbH Germany
- Hospira
- India Department of Industrial Policy and Promotion (DIPP)
- India Planning Commission
- Indian Ministry of Chemicals and Fertilizers
- Insurance Regulatory and Development Authority of India
- International Diabetes Federation (IDF)
- IPCA Laboratories
- IsoRay
- Janssen Pharmaceutica N.V.
- Japan PMDA
- Jubilant Biosys Pte. Ltd.
- Jubilant Cadista Pharmaceuticals Inc.
- Jubilant Discovery Services Inc.
- Jubilant HollisterStier General Partnership
- Jubilant Life Sciences
- Jubilant Life Sciences (Shanghai) Limited
- Jubilant Life Sciences (USA) Inc.
- Laboratories Grin S.A. de C.V.
- Laboratorios Combix S.L
- Laboratorios Torrent (Malaysia) SDN.BHD. Malaysia
- Laboratorios Torrent, S.A. de C.V. Mexico
- Litha
- Lupin Ltd
- MCC South Africa
- Medicamenta a.s
- Medicine San Frontier
- Medpro Pharmaceutica (Pty) Ltd
- Medquímica Indústria Farmacêutica S.A.,
- Merck Serono
- Merind
- Mnemosyne Pharma. Inc.
- Multicare Pharmaceuticals
- Mylan
- Nanomi BV
- Natco Pharma
- National Pharmaceutical Pricing Authority (NPPA)
- Natrol
- Negma,
- Nesher Pharmaceuticals
- Norispharm GmbH Germany
- Novartis
- Novel Laboratories Inc.
- OctoPlus
- Orchid Chemicals
- Organisation for Economic Co-operation and Development (OECD)
- Organisation of the Pharmaceutical Producers of India (OPPI)
- Orion Corp.
- Oscient Pharmaceuticals
- Otsuka Pharmaceutical Co., Ltd
- Panacea Biotec Ltd
- Pfizer
- Pharma Dynamics
- Pinewood Laboratory
- Piramal
- PromiusPharma
- Ranbaxy
- Roche
- S&D Pharma
- Salix Pharmaceuticals
- Sanofi
- Societe Marocaine De Cooperation Pharmaceutique
- Spimaco
- Strides Arcolab Ltd
- Sun Pharmaceutical Industries Ltd
- Taro
- Temmler Pharma GMBH & Co
- The Pharmaceutical Institute (PHI).
- Torrent Australasia Pty Ltd. Australia
- Torrent Do Brasil Ltda Brazil
- Torrent Pharma (Thailand) Co., Limited. Thailand
- Torrent Pharma (UK) Ltd (TPUK) United Kingdom
- Torrent Pharma Canada Inc. Canada
- Torrent Pharma France S.A.S. France
- Torrent Pharma GmbH (TPG) Germany
- Torrent Pharma Inc. USA
- Torrent Pharma Philippines Inc. Philippines
- Torrent Pharma S.R.L. Romania
- Torrent Pharmaceuticals Limited
- UK Medicines & Healthcare products Regulatory Agency (UK MHRA / MHRA)
- URL Pharma
- US Federal Trade Commission
- US Food & Drug Administration (USFDA / FDA)
- Wallis Laboratory
- Wockhardt Limited
- World Bank
- World Health Organisation (WHO)
- World Trade Organization
- Yoshindo Inc.
- Zao Torrent Pharma Russia
- Zydus BSV Pharma Pvt. Ltd.
- Zydus Cadila
- Zydus Cadila Healthcare Ltd
- Zydus Discovery DMCC
- Zydus Hospira Oncology Pvt. Ltd.
- Zydus Takeda Healthcare Pvt. Ltd.
- Zydus Worldwide DMCC
- Zyg Pharma Private Limited